EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Defining rapid early progression in glioblastoma—A volumetric approach

Vikram Munlapudi iD, Jacob Guzzino iD, David J Crompton, Shubhi Agarwal, Eric J Lehrer, Shelby Kern, Aaron Bogan, Sujay A Vora, Alfredo Quinones-Hinojosa iD, Terry C Burns, Wendy J Sherman, Paul D Brown und 7 weitere

Neuro-Oncology Advances · 12.01.2026 · 8 (1)

DOI: 10.1093/noajnl/vdag153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 08.06.2026. Verfasst von Vikram Munlapudi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, Florida, USA. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The current treatment of glioblastoma involves resection followed by radiotherapy (RT) and temozolomide. Rapid early progression (REP) of tumor in the surgery-to-radiotherapy interval (SRI) has been described using categorical or semi-quantitative assessments and is associated with inferior clinical outcomes. This study seeks to establish and validate a quantitative definition for REP and examine how REP could inform future therapy.

Methods

Volumes of tumor and resection cavity at 3 time points—preoperative, postoperative and RT-planning (pre-RT)—were contoured among patients who had undergone standard of care. A minimal, but clinically appreciable, threshold for defining REP based on change in tumor volume was established, validated, and subsequently used to assess actionable predictors of REP and its prognostic value.

Results

An increase of >2 cc in volume or a new satellite tumor between the post-operative to planning MRI was found to be a sensitive, pragmatic, and statistically significant cutoff for REP (P = .002). Actionable predictors such as SRI of 6 weeks and a > 5 cc residual immediate post-operative tumor volume were found to be statistically significant predictors of REP. REP was also found to be a statistically significant prognostic indicator for overall survival (P = .002) and progression-free survival.

Conclusion

These findings support that an increase in tumor volume between post-operative and pre-RT MRI of >2 cc is the ideal working definition of REP in this clinical setting. Furthermore, REP could serve as a prognostic ­biomarker to track treatment response. Additionally, 2 actionable predictors of REP, post-op residual tumor volume and SRI, are identified.

Schlagwörter

Stichwörter der Autor:innen

glioblastomarapid early progressionresidual tumorvolumetric analysis

Autor:innen und Institutionen

  • Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, Florida, USA.
  • Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, Minnesota, USA.
  • Department of Research Biostatistics, Mayo Clinic Arizona, Phoenix, Arizona, USA.
  • Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
  • Department of Neurosurgery, Mayo Clinic Florida, Jacksonville, Florida, USA.
  • Department of Neurosurgery, Mayo Clinic Rochester, Rochester, Minnesota, USA.

ORCID-Profile: Vikram Munlapudi, Jacob Guzzino, Alfredo Quinones-Hinojosa, William G Breen, Daniel M Trifiletti

Zitieren

APA

Munlapudi, V., Guzzino, J., Crompton, D. J., Agarwal, S., Lehrer, E. J., Kern, S., Bogan, A., Vora, S. A., Quinones-Hinojosa, A., Burns, T. C., Sherman, W. J., Brown, P. D., Laack, N., Peterson, J., Uhm, J. H., Ruff, M. W., Sener, U. T., Breen, W. G., & Trifiletti, D. M. (2026). Defining rapid early progression in glioblastoma—A volumetric approach. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag153

Vancouver

Munlapudi V, Guzzino J, Crompton DJ, Agarwal S, Lehrer EJ, Kern S, et al. Defining rapid early progression in glioblastoma—A volumetric approach. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag153

BibTeX
@article{Munlapudi2026,
  author = {Munlapudi, Vikram and Guzzino, Jacob and Crompton, David J and Agarwal, Shubhi and Lehrer, Eric J and Kern, Shelby and Bogan, Aaron and Vora, Sujay A and Quinones-Hinojosa, Alfredo and Burns, Terry C and Sherman, Wendy J and Brown, Paul D and Laack, Nadia and Peterson, Jennifer and Uhm, Joon H and Ruff, Michael W and Sener, Ugur T and Breen, William G and Trifiletti, Daniel M},
  title = {Defining rapid early progression in glioblastoma—A volumetric approach},
  journal = {Neuro-Oncology Advances},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1093/noajnl/vdag153}
}
Kostenlos starten →